The Reproductive Freedom Alliance (RFA)–a nonpartisan coalition of 23 governors committed to protecting and expanding reproductive freedom–today submitted a statement for the record to the Chair and Ranking Member of the Senate Committee on Health, Education, Labor, and Pensions (HELP). The statement is in connection with the HELP Committee hearing on medication abortion on January 14 and calls on lawmakers to reject politicized, non-peer reviewed claims that contradict decades of scientific evidence.
“For more than 25 years, mifepristone has been proven safe and effective through rigorous scientific review and decades of real-world use. Across the United States, medical providers rely on this medication as a critical component of comprehensive reproductive health care,” said Christina Chang, Executive Director of the Reproductive Freedom Alliance. “Current efforts to re-litigate the safety of FDA-approved medications are driven by politics, not science, and threaten patient care and the integrity of our public health system. RFA urges Congress to respect the scientific evidence and safety record and uphold continued access to mifepristone.”
About the Reproductive Freedom Alliance
The Reproductive Freedom Alliance (RFA) is a nonpartisan coalition of 23 governors working together to protect and expand access to reproductive health care, defend the rights of patients and providers, and advance state policies that safeguard reproductive freedom. RFA is supported by GovAct, a fiscally sponsored nonpartisan nonprofit initiative.